試す 金 - 無料
Why Sebi Rules on Research Analysts Ease Entry Barrier But Raise Stakes
Mint Bangalore
|February 18, 2025
These new obligations seem to impose an excessive compliance burden on RAs
Recent changes by the Securities and Exchange Board of India (Sebi) to the regulatory framework governing research analysts (RAs) reflect a mix of progressive and regressive measures. One of the notable changes is the relaxation of eligibility criteria, which may seem like a welcome step. However, the new framework imposes burdensome obligations that could hinder RAs' ability to operate effectively.
The minimum qualification requirement for an individual RA or a principal officer of a non-individual RA has been reduced to a graduate degree in a finance-related field. Additionally, the previous requirement of five years of experience in securities-related activities has been completely removed.
While this change lowers entry barriers for an individual seeking registration as an RA, it also raises concerns about the research quality provided by them, as individuals with only a finance-related graduate degree can now register with Sebi and issue research reports without any prior experience in the securities market. A more balanced approach might have been to introduce a reduced but reasonable experience threshold instead of its outright elimination.
このストーリーは、Mint Bangalore の February 18, 2025 版からのものです。
Magzter GOLD を購読すると、厳選された何千ものプレミアム記事や、10,000 以上の雑誌や新聞にアクセスできます。
すでに購読者ですか? サインイン
Mint Bangalore からのその他のストーリー
Mint Bangalore
A modern-day throwback to 'Malgudi Days'
Sita Bhaskar's latest novel revisits writer R.K. Narayan’s legacy to explore class, caste, and community in Mysuru
4 mins
December 13, 2025
Mint Bangalore
Come for the 'baithak', stay for the shopping
Fashion brands are hosting workshops, talks, music gigs and 'baithaks' to take a culture-first approach to customer loyalty
4 mins
December 13, 2025
Mint Bangalore
Novo Nordisk debuts Ozempic at ₹2,200 a week
Danish drugmaker Novo Nordisk on Friday launched its blockbuster diabetes drug Ozempic in India, with a starting price of ₹2,200 per week.
1 mins
December 13, 2025
Mint Bangalore
Tushar Adhav and politics of the dance floor
There's a 1983 song by English new wave band Re-Flex that keeps popping up in my mind every time I find myself on an Indian club floor.
4 mins
December 13, 2025
Mint Bangalore
English's place in history is not black and white
In 1784, two white men joined forces to establish an English school in Thanjavur, Tamil Nadu.
4 mins
December 13, 2025
Mint Bangalore
Rajasthan limits e-NAM 2.0 pilot amid snags; 1.0 to stay
The Centre restricted e-NAM 2.0 pilot to 10 mandis, including Tonk, Jodhpur and Sujangarh
3 mins
December 13, 2025
Mint Bangalore
GST cuts, easing inflation drive rural demand revival
India’s rural economy expanded and recovered strongly in late 2025, with consumption, incomes and investment improving after a key tax reform and as inflation eased, a survey showed.
2 mins
December 13, 2025
Mint Bangalore
Sebi weighs easier unified penalty rules for listed cos
Explores framework like the one for brokers that standardized and reduced fines
2 mins
December 13, 2025
Mint Bangalore
The loss of Srinagar as a cosmopolitan city
Sameer Hamdani's book brings alive the details that once defined life in one of South Asia's oldest cities but stops short of reflecting on the present
5 mins
December 13, 2025
Mint Bangalore
'We need 100 Earths to sustain generative Al'
Karen Hao, author of ‘Empire of AI’, explains how AI and tech companies are no less than extractive colonial empires
4 mins
December 13, 2025
Listen
Translate
Change font size
